Literature DB >> 22379406

Neoplasms of anal canal and perianal skin.

Daniel Leonard1, David Beddy, Eric J Dozois.   

Abstract

Tumors of the anus and perianal skin are rare. Their presentation can vary and often mimics common benign anal pathology, thereby delaying diagnosis and appropriate and timely treatment. The anatomy of this region is complex because it represents the progressive transition from the digestive system to the skin with many different co-existing types of cells and tissues. Squamous cell carcinoma of the anal canal is the most frequent tumor found in the anal and perianal region. Less-frequent lesions include Bowen's and Paget's disease, basal cell carcinoma, melanoma, and adenocarcinoma. This article aims to review the clinical presentation, diagnostic evaluation, and treatment options for neoplasms of the anal canal and perianal skin.

Entities:  

Keywords:  Anal squamous-cell carcinoma; anal Bowen's disease; anal Paget's disease; anal adenocarcinoma; anal basal-cell carcinoma; anal melanoma

Year:  2011        PMID: 22379406      PMCID: PMC3140334          DOI: 10.1055/s-0031-1272824

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  70 in total

1.  Practice parameters for anal squamous neoplasms.

Authors:  Phillip R Fleshner; Sridhar Chalasani; George J Chang; David H Levien; Neil H Hyman; W Donald Buie
Journal:  Dis Colon Rectum       Date:  2007-11-21       Impact factor: 4.585

Review 2.  Anal canal and perianal epidermoid cancers.

Authors:  P R Fuchshuber; M Rodriguez-Bigas; T Weber; N J Petrelli
Journal:  J Am Coll Surg       Date:  1997-11       Impact factor: 6.113

3.  Anorectal melanoma--an incurable disease?

Authors:  C Thibault; P Sagar; S Nivatvongs; D M Ilstrup; B G Wolff
Journal:  Dis Colon Rectum       Date:  1997-06       Impact factor: 4.585

4.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

Review 5.  Sentinel lymph node in carcinoma of the anal canal: a review.

Authors:  D C Damin; M A Rosito; G Schwartsmann
Journal:  Eur J Surg Oncol       Date:  2005-11-08       Impact factor: 4.424

6.  Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.

Authors:  B M Boman; C G Moertel; M J O'Connell; M Scott; L H Weiland; R W Beart; L L Gunderson; R J Spencer
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

Review 7.  Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.

Authors:  Brooke E Hoots; Joel M Palefsky; Jeanne M Pimenta; Jennifer S Smith
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

8.  A twenty-year experience with adenocarcinoma of the anal canal.

Authors:  George J Chang; Ricardo J Gonzalez; John M Skibber; Cathy Eng; Prajnan Das; Miguel A Rodriguez-Bigas
Journal:  Dis Colon Rectum       Date:  2009-08       Impact factor: 4.585

9.  Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Authors:  Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles R Thomas; Robert J Mayer; Michael G Haddock; Tyvin A Rich; Christopher Willett
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272

10.  Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.

Authors:  Dan E Schiller; Bernard J Cummings; Sundeep Rai; Lisa W Le; Linda Last; Phil Davey; Alexandra Easson; Andrew J Smith; Carol J Swallow
Journal:  Ann Surg Oncol       Date:  2007-07-20       Impact factor: 5.344

View more
  29 in total

1.  Perianal multiple Bowen's disease: a case report.

Authors:  Wei Zhan; Xin Liao; Tian Tian; Ru-Yi Zhang; Po Li; Xiao-Ping Wu; Qing-Hua Ji; Qin Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Anorectal Melanoma with Bilateral Ovarian Metastases.

Authors:  Harjeet Singh; Rahul Gupta; Rakesh Kapoor; Ritambhra Nada; Rajinder Singh
Journal:  J Gastrointest Cancer       Date:  2016-03

Review 3.  Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations.

Authors:  Gwendolyn P Quinn; Julian A Sanchez; Steven K Sutton; Susan T Vadaparampil; Giang T Nguyen; B Lee Green; Peter A Kanetsky; Matthew B Schabath
Journal:  CA Cancer J Clin       Date:  2015-07-17       Impact factor: 508.702

4.  Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation?

Authors:  L Pettit; S Meade; P Sanghera; J Glaholm; J I Geh; A Hartley
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

5.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

Review 6.  Anal cancer treatment: current status and future perspectives.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Pamela Abdayem; Joelle Antoun; Dolly Nasr
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

7.  Surgery and chemotherapy are associated with improved overall survival in anal adenocarcinoma: results of a national cohort study.

Authors:  Nicholas P McKenna; John R Bergquist; Elizabeth B Habermann; Heidi K Chua; Scott R Kelley; Kellie L Mathis
Journal:  Int J Colorectal Dis       Date:  2019-01-11       Impact factor: 2.571

8.  Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.

Authors:  Elizabeth A Stier; Stephen E Goldstone; Mark H Einstein; Naomi Jay; John M Berry; Timothy Wilkin; Jeannette Y Lee; Teresa M Darragh; Maria Da Costa; Lori Panther; David Aboulafia; Joel M Palefsky
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

9.  Perianal melanoma with a BRAF gene mutation in a young Portuguese Roma native.

Authors:  Jennifer Tan
Journal:  BMJ Case Rep       Date:  2016-02-15

10.  Loss of Raf kinase inhibitor protein expression is associated with human papillomavirus 16 infection in anal tumors.

Authors:  Lucas Tadeu Bidinotto; Carlos A R Véo; Edgar Aleman Loaiza; Guilherme G Ribeiro; Adriana T Lorenzi; Luciana Albina Reis Rosa; Cristina Mendes De Oliveira; José Eduardo Levi; Cristovam Scapulatempo-Neto; Adhemar Longatto-Filho; Rui Manuel Reis
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.